Endoplasmic reticulum stress and apoptosis contribute to the pathogenesis of dominantly inherited isolated GH deficiency due to GH1 gene splice site mutations

Endocrinology. 2013 Sep;154(9):3228-39. doi: 10.1210/en.2013-1249. Epub 2013 Jun 4.

Abstract

Dominantly inherited isolated GH deficiency is mainly caused by a heterozygous donor site mutation of intron 3 in the GH1 gene. An exon 3 deletion in GH (del32-71 GH) is produced from a mutant allele, whereas wild-type GH is produced from the other allele. Several studies have demonstrated a dominant negative effect of del32-71 GH on wild-type GH secretion, but the precise molecular mechanisms remain unclear. We hypothesized that unfolded del32-71 GH accumulates in the endoplasmic reticulum (ER) and causes ER stress and apoptosis in somatotrophs, promoting GH deficiency. To evaluate del32-71 GH-mediated ER stress, we established GH4C1 cell lines with doxycycline (dox)-controlled del32-71 GH expression. In 20 of 23 dox-controlled cell lines, the concentration of wild-type GH in the culture medium significantly decreased with del32-71 GH induction, demonstrating the dominant negative effect of this mutant. Cell viability, mRNA abundance of ER stress-response genes, caspase activation, and DNA fragmentation were evaluated in 5 dox-controlled cell lines selected as cellular models. In 4 of the 5 cell lines, del32-71 GH induction decreased cell viability, increased expression of 3 major ER stress response pathways (PRKR-like endoplasmic reticulum kinase [PERK], activating transcription factor-6 [ATF6], and inositol requirement 1 [IRE1]), and induced caspase-3 and caspase-7 activation. In 1 of the 4 cell lines, DNA fragmentation was demonstrated. Finally, overexpression of XBP1(S), a nuclear transcription factor downstream of IRE1, completely reversed the observed caspase activation. These data suggested that del32-71 GH-mediated ER stress and apoptosis contributed to the decrease in wild-type GH secretion observed in GH deficiency due to the GH1 gene slice-site mutations.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alleles
  • Animals
  • Anti-Bacterial Agents / pharmacology
  • Apoptosis* / drug effects
  • Cell Line
  • Cell Survival / drug effects
  • Clone Cells
  • Doxycycline / pharmacology
  • Dwarfism, Pituitary / genetics*
  • Dwarfism, Pituitary / metabolism
  • Endoplasmic Reticulum Stress* / drug effects
  • Gene Deletion
  • Human Growth Hormone / genetics*
  • Human Growth Hormone / metabolism
  • Humans
  • Mutation*
  • Promoter Regions, Genetic / drug effects
  • RNA Splice Sites*
  • Rats
  • Recombinant Proteins / metabolism
  • Reproducibility of Results
  • Signal Transduction / drug effects
  • Somatotrophs / drug effects
  • Somatotrophs / metabolism*
  • Somatotrophs / ultrastructure
  • Up-Regulation / drug effects

Substances

  • Anti-Bacterial Agents
  • RNA Splice Sites
  • Recombinant Proteins
  • Human Growth Hormone
  • Doxycycline

Supplementary concepts

  • Isolated Growth Hormone Deficiency, Type II